8 stories mentioning SASE:4013
Every FINWIRES story that references SASE:4013, newest first.
EFG-Hermes Brokerage on Sunday lowered its price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 250 Saudi riyals from 260 riyals, while keeping its neutral rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Arqaam Capital on Tuesday reduced its price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 255 Saudi riyals from 270 riyals, while maintaining its sell rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
AlphaMena on Thursday lowered the price target for Saudi Arabian medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 182.00 Saudi riyals from 210.00 riyals and reiterated its sell rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
HSBC on Wednesday decreased the price target for medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 306 Saudi riyals from 320 riyals, while affirming its buy rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Ubhar Capital Oman on Monday downgraded Saudi medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to hold from buy and lowered its price target to 247.10 Saudi riyals from 278.00 riyals.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Arqaam Capital on Sunday downgraded Saudi medical group Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to sell from buy and decreased its price target to 270.00 Saudi riyals from 280.00 riyals.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Arqaam Capital on Wednesday reduced its price target for medical company Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to 280 Saudi riyals from 300 riyals, keeping its buy rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
SNB Capital on Wednesday raised Saudi Arabian medical company Dr. Sulaiman Al Habib Medical Services Group (SASE:4013) to overweight from neutral, while decreasing its price target to 291.70 Saudi riyals from 293.60 riyals.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)